Select for export Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513851 PubMed 24399338 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2013-12-31 Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL PubMed Published psilocybin Addiction Other More
Select for export Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1874473708666150107121331 PubMed 25563443 Copy citation Copy BibTeX Current Drug Abuse Reviews 2013-12-31 Garcia-Romeu A, Griffiths RR, Johnson MW. Europe PMC Published psilocybin AddictionPersonality ChangeSpirituality Other More
Select for export Psilocybin--summary of knowledge and new perspectives. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2013.12.006 PubMed 24444771 Copy citation Copy BibTeX Unknown journal 2013-12-16 Tylš F, Páleníček T, Horáček J. Europe PMC Published psilocybin Brain ImagingPharmacologyAging Review Article More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export Psychedelics and mental health: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0063972 PubMed 23976938 Copy citation Copy BibTeX PLoS ONE 2013-08-18 Krebs TS, Johansen PØ. Europe PMC Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export Serotonergic hallucinogens as translational models relevant to schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1461145713000722 PubMed 23942028 Copy citation Copy BibTeX Unknown journal 2013-08-12 Halberstadt AL, Geyer MA. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Review Article More
Select for export PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/jnnp-2013-306103.17 Copy citation Copy BibTeX Journal of Neurology Neurosurgery & Psychiatry 2013-08-05 Robin Carhart-Harris OpenAlex Published psilocybin AnxietyEnd-of-Life DistressBrain Imaging Clinical Trial More
Select for export Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1503/jpn.120128 Copy citation Copy BibTeX Фундаментальные исследования (Fundamental Research) 2013-02-28 Young SN. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neulet.2012.12.053 PubMed 23333599 Copy citation Copy BibTeX Unknown journal 2013-01-15 Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J. Europe PMC Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Animal models of serotonergic psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cn300138m PubMed 23336043 Copy citation Copy BibTeX Unknown journal 2012-09-23 Hanks JB, González-Maeso J. Europe PMC Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Review Article More
Select for export Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms' Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Pure Amsterdam UMC 2012-05-31 Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen OpenAlex Published psilocybinpsilocin End-of-Life DistressPharmacologyReceptor Pharmacology Case Report More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2680-6 PubMed 22526529 Copy citation Copy BibTeX Unknown journal 2012-04-12 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Europe PMC Published psilocybin AnxietyHeadache / MigraineSpirituality Observational Study More
Select for export Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.26.1_supplement.1043.3 Copy citation Copy BibTeX The FASEB Journal 2012-03-31 Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Zhongguo Yike Daxue xuebao 2011-12-31 LI Yu-bai OpenAlex Published psilocybin PharmacologyReceptor PharmacologyOxidative Stress Other More
Select for export Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1163/187847612x646956 Copy citation Copy BibTeX Seeing and Perceiving 2011-12-31 David Luke, Devin B. Terhune, Ross Friday OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Observational Study More
Select for export Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881111420188 PubMed 21956378 Copy citation Copy BibTeX Journal of Psychopharmacology 2011-09-27 MacLean KA, Johnson MW, Griffiths RR. Europe PMC Published psilocybin Personality ChangeCreativitySpirituality Randomized Controlled Trial More
Select for export Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nrl.2011.07.003 PubMed 21893367 Copy citation Copy BibTeX Unknown journal 2011-09-02 Carod-Artal FJ. Europe PMC Published psilocybin AddictionConsciousnessReview Article Review Article More
Select for export Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2011.605699 PubMed 22111404 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2011-06-30 Kjellgren A, Soussan C. Europe PMC Published psilocybin Emotional ProcessingAdolescents Qualitative Study More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
